Navigation Links
Speeding 'fingertip' discovery -- 20 years of protein info in 1 place

Researchers at Johns Hopkins took advantage of a new technique that reads the makeup of proteins to identify nearly all chemical changes nature makes by adding phosphate to proteins manufactured in human cells.

The Hopkins team then added its list of these so-called phosphorylation events to lists compiled by others and created a publicly available database on the Web - PhosphoMotif Finder [ http://www.hprd.org/PhosphoMotif_finder ] - to help speed the work of researchers around the world.

“Finding so many at one time is a huge advance,?says Akhilesh Pandey, M.D., Ph.D., an associate professor at the McKusick-Nathans Institute of Genetic Medicine at Hopkins. “Phosphorylation is essential for controlling chemical reactions in our cells?protein factories, and phosphorylation gone awry has been implicated in several diseases. The ability to study more than one phosphorlyation at a time will help us understand some of these diseases - including cancers - sooner.

“What we have here is about 20 years?worth of lots of work in one searchable list,?says Pandey. A report on all of the newly identified protein alterations is published in the Feb. 13 issue of the Proceedings of the National Academy of Sciences, while a report on the database appears in the March issue of Nature Biotechnology.

Pandey’s team used electron transfer dissociation (ETD) tandem mass spectrometry, a technology that breaks apart proteins into small fragments, separates them by size and identifies the fragments based on their mass - their size and weight. The process improves on previous techniques by breaking up proteins more gently and keeping chemical modifications like phosphorylation intact. Previous spectrometry methods were “just too rough?on the delicate protein alterations and sheared them right off, he says. “We had to guess where they might be and nobody wants to chase false leads based on wrong gues ses.?

Pandey says the original goal of the research was to identify accurately as many protein changes as possible using the new technology. “But to see how well we measured up, we had to compare our findings to what already was published, and there was just no clean, easy way of doing that because there were reports all over the place.

“That’s when we decided to go through and consolidate just about everything on phosphorylation that was out there.?

Working with human kidney cells, the researchers fished out the thousands of different proteins and analyzed them by ETD, resulting in a net total of 1,435 phosphorylations. Comparing these 1,435 to the 20 years?of published data, they discovered that about 80 percent of what they found never had been reported.

The team then constructed an online search tool, PhosphoMotif Finder, which was incorporated into their previously established Human Protein Reference Database. Human Protein Reference Database now contains about 16,000 phosphorylation sites described in the literature and the PhosphoMotif Finder tool allows any researcher to find potential phosphorylation sites in any protein of interest.

“The power of this technique is not just in the numbers,?says Pandey. “Rather, we’ve found what you might call new information about old proteins, and we hope the new data will help researchers study their favorite proteins in greater depth. After all, there’s no sense in reinventing the wheel.?

Pandey and his team now are curious about other chemical modifications of proteins, which are the “business-end?products of our genes. “There is evidence of other, more fragile modifications that until now no one has been able to get a handle on because they’re way too hard to work with. Now we have the tools to probe further,?he says.
'"/>

Source:Johns Hopkins Medical Institutions


Related biology news :

1. Speeding discovery of the human cancer genome
2. Speeding the search for elusive chromosomal errors
3. Protein discovery could unlock the secret to better TB treatment
4. Purdue proves concept of using nano-materials for drug discovery
5. UCSD discovery may help extend life of natural pesticide
6. Leprosy microbes lead scientists to immune discovery
7. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
8. Researchers make surprise discovery that some neurons can transmit three signals at once
9. Important discovery about second most fatal cancer
10. Harmless virus may hold key to more effective HIV drug discovery
11. Fundamental discovery -- Bone fracture

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
(Date:2/16/2017)... (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the power of ... negative breast cancer (TNBC), announced today their completion of the ... The YEi Start in France ... business in France and Europe.  ImMAGE ... an intensive one week immersion in France ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology: